American Medical Association Text-friendly versionSearch our SiteWeb GuidelinesPrivacy StatementSitemapContact UsRenewJoinHome
Text-friendly version AMA Home>Policy and Advocacy>AMA in Washington>White House/Agencies>Committees/Agencies> >Medicare Coverage Advisory Committee
Medicare Coverage Advisory Committee EMAIL THIS STORY  PRINT THIS STORY

HCFA Medicare Coverage Criteria Comments
Statement Regarding Discussion Paper on Evaluating Effectiveness
Letter to HCFA Regarding the First Meeting of the Medicare Coverage Advisory Committee
 

Statement Regarding Discussion Paper on Evaluating Effectiveness

AMA statement to the Medicare Coverage Advisory Committee

March 1, 2000

Statement to Medicare Coverage Advisory Committee (MCAC) Executive Committee from E. Ratcliffe Anderson Jr., MD
Executive Vice President and CEO, American Medical Association
RE: Discussion Paper on Evaluating Effectiveness


After the first MCAC Executive Committee meeting in December, I wrote to Nancy-Ann DeParle to say that the American Medical Association (AMA) was impressed and gratified by the commitment of the advisors and the Health Care Financing Administration (HCFA) to ensuring that MCAC recommendations would be grounded in scientific evidence of clinical effectiveness. I also said that the meeting made it clear that she had fulfilled her promise to create an open, timely, and accountable process for making national coverage decisions.

The discussion paper that the committee members prepared for today’s meeting certainly underscores the observations we made in December. The recommendations for evaluating evidence clearly state the key issues to consider in assessing the state of the knowledge regarding medical interventions proposed for Medicare coverage. We are pleased that, in addition to recommending a critical review of evidence from clinical trials, the Executive Committee recommends that the “standard of excellence” for the evidence report include work developed by the national medical specialty societies. We also commend the advisors for recommending that panel members take an active role in framing the questions to be addressed by the evidence report, participate in the report’s preparation, and seek external review of the evidence reports.

Prior to the MCAC’s formation, the AMA had expressed concern that Medicare coverage decisions might be driven to a large degree by the information presented by those with a vested interest in coverage instead of by the available scientific and clinical evidence. The discussion paper developed by the advisors has allayed our concerns in this regard, and we encourage adoption of its recommendations.


Last updated: Apr 12, 2001

© Copyright 1995-2001 American Medical Association. All rights reserved.